Molecule Details
| InChIKey | GQRWEJRYCBEXLY-UHFFFAOYSA-N |
|---|---|
| Compound Name | 2,6-bis(chloranyl)-4-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]-~{N}-(1,3,5-trimethylpyrazol-4-yl)benzenesulfonamide |
| Canonical SMILES | Cc1nn(C)c(C)c1NS(=O)(=O)c1c(Cl)cc(-c2ccnc(N3CCN(C)CC3)c2)cc1Cl |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.42 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (3)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P30419 | NMT1 | Homo sapiens | Human | PF01233 PF02799 | 7.9 | Ki | ChEMBL;BindingDB |
| Q4Q5S8 | NMT | Leishmania major | Pathogen | PF01233 PF02799 | 8.2 | Ki | ChEMBL;BindingDB |
| Q388H8 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | Pathogen | PF01233 PF02799 | 6.2 | IC50 | ChEMBL |